The objective of this study was to describe the epidemiological, clinical, paraclinical and etiological profiles of hyperthyroidism at Kara Teaching Hospital. This was a retrospective study of the records of patients followed for hyperthyroidism in the internal medicine and endocrinology department of the Kara Teaching Hospital from June 2021 to March 2023. During this study period, 33 (2.24%) of the 1476 patients had hyperthyroidism. Women accounted for 81.82% of cases. The mean age was 44.72 +/- 15.76 with extremes ranging from 10 to 71 years. Goiter was found in 78.79% of cases, followed by asthenia 72.73% and tachycardia 60.61%. The causes of hyperthyroidism were Graves' disease in 36.36% of cases, thyroiditis in 30.30% of cases, toxic multinodular goiter in 27.27% of cases, and toxic nodule in 6.06% of cases. 6% of patients had complications such as cardiothyreosis. The course with synthetic antithyroids was favorable with normalization of thyroid hormones. Finally, 30% of the patients had been operated on. Hyperthyroidism is very common in hospitals in Kara with a female predominance. The clinical signs are varied and the main cause is Graves' disease.
| Published in | International Journal of Diabetes and Endocrinology (Volume 8, Issue 4) |
| DOI | 10.11648/j.ijde.20230804.14 |
| Page(s) | 60-63 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Hyperthyroidism, Thyrotoxicosis, Goiter, CHU Kara
| [1] | Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016; 26 (10): 1343-421. doi: 10.1089/thy.2016.0229. |
| [2] | Wémeau J-L, Cardot-Bauters C, d’Herbomez-Boidein M, Périmenis P, Céphise-Velayoudom F-L. Hyperthyroïdie. EMC - Endocrinologie – Nutrition 2006; 3. |
| [3] | Djrolo F, Gninkoun J et traoré Goita S. Profil épidémiologique et clinique des hyperthyroidies au CNHU de Cotonou. Annales d'Endocrinologie. 2016; 77 (4): 399-400. |
| [4] | Balaka A, Tchamdja T, Kodjo K, Djalogue L, Djagadou KA, Nemi KD et al. Dysthyroidies in hospital environment in Lomé (Togo). RAFMI. 2022; 9 (1): 38-43. |
| [5] | Mbadinga H, Nkoua JL, Kibeke P, Bikandou G, Nsakala-kibangou N. Hyperthyroidies: aspects étiologiques et cliniques: étude de 72 cas au chu de Brazzaville (congo). Médecine d'Afrique Noire. 1997; 44 (6): 342-4. |
| [6] | Koffi Dago P, Fagnidi F, Lokrou A, Danho J, Abodo J, Hue A et al. Les Hyperthyroïdies à Abidjan: Aspects Cliniques, Biologiques, Thérapeutiques et Évolutifs à Propos de 399 Cas. Health Sci. Dis. 2019; 20 (6): 23-6. |
| [7] | Dionadji, M., Abbas, O., & Mbero, M. Caractéristiques Cliniques et Biologiques de l’Hyperthyroïdie à N’Djamena. Health Sci. Dis. 2015; 16 (4): 1-3. Retrieved from https://www.hsd-fmsb.org/index.php/hsd/article/view/590 |
| [8] | Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995; 273 (10): 808-12. PMID: 7532241. |
| [9] | Balaka A, Djagadou KA, Tchamdja T, Mossi E, Nemi KD, Djibril AM. La maladie de Basedow: aspects épidémio-logiques, diagnostiques et évolutifs au CHU Sylvanus Olympio de Lomé. Rev Afr End Métab Nut. 2016; 2 (3): 6-9. |
| [10] | Agoda-Koussema L, Adjenou K, Amana B, Goeh Akue K. Aspects échographiques des anomalies de la thyroïde à propos de 134 cas. Méd d’Afr Noire. 2008; 55 (11): 573-8. |
| [11] | Akossou SY, Naporn A, Goeh-Akue E. Les difficultés de la prise en charge de la thyréotoxicose en Afrique Noire. Ann Endocrinol. 2001; 62: 516-20. |
| [12] | Sabi KA, Amekoudi EYM, Noto-Kadou- Kaza B, Vigan J, Tia WM, Mossi KE et al. Profil et facteurs de risques des dysthyroïdies chez l’hémodialysé chronique au Togo: étude multicentrique de 119 hémodialysés chroniques. J Res Sci univ Lomé. 2017; 19 (1): 1-4. |
| [13] | Bensalem H. profils hormonaux thyroïdiens des patients atteints d’hyperthyroïdie thèse. Cheick Anta Diop: Université Cheick Anta Diop; 2017. 71p. |
| [14] | Amadou Diop Dia, Diatou Gueye Dia, Cheikh Tidiane Tall, Awa Cheikh Ndao, Nafy Diagne, Nafy Ndiaye et al. Les Hyperthyroïdies à Saint-Louis du Sénégal: Prise en Charge Diagnostique et Thérapeutique. Health Sci. Dis. 2022; 23 (3): 30-33. |
| [15] | Brah S, Mahamane Sani M A, Daou M, Andia A, Bade M A, Bakasso R et al. Les Dysthyroïdies à l’Hôpital National de Niamey. Health Sci. Dis. 2016; 17 (4): 36-40. |
| [16] | Hélène Lasolle et Françoise Borson-Chazot. Hyperthyroïdies. In: L. Guilevn, L Mouthon, H Lévesque. Traité de médecine, 5éd. paris, TdM éditions, 2019-S21-P02-C01: 1-6. |
| [17] | Sidibe EH, Fall L, Toure-Sow H, Sow AM. Hyperthyroïdieaprès 50 ans en milieu Sénégalais. Etude de 31 cas colligés en 14 ans. Rev Med Int 1998; 19: 237-41. |
| [18] | Togo A, Kante L, Diakite I, Traore A, Maiga A, Samake A et al. Goitres bénins hyperthyroïdiens en chirurgie générale CHU Gabriel Touré Mali: aspects épidémiologiques et diagnostiques. Méd. d'Afr noire. 2010; 57: 61-4. |
| [19] | Yaméogo AA, Yaméogo N V, Compaoré Y D, Ouédraogo T L, Zabsonré P. La cardiothyréose au centre hospitalier universitaire de Bobo-Dioulasso, Burkina Faso. Pan Afr Med J. 2012; 11: 38. |
APA Style
Lihanimpo, D., Komi Edem, M., Toyi, T., Kodjo Agbeko, D., Abago, B., et al. (2023). Hyperthyroidism at Kara Teaching Hospital About 33 Cases Studies. International Journal of Diabetes and Endocrinology, 8(4), 60-63. https://doi.org/10.11648/j.ijde.20230804.14
ACS Style
Lihanimpo, D.; Komi Edem, M.; Toyi, T.; Kodjo Agbeko, D.; Abago, B., et al. Hyperthyroidism at Kara Teaching Hospital About 33 Cases Studies. Int. J. Diabetes Endocrinol. 2023, 8(4), 60-63. doi: 10.11648/j.ijde.20230804.14
AMA Style
Lihanimpo D, Komi Edem M, Toyi T, Kodjo Agbeko D, Abago B, et al. Hyperthyroidism at Kara Teaching Hospital About 33 Cases Studies. Int J Diabetes Endocrinol. 2023;8(4):60-63. doi: 10.11648/j.ijde.20230804.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijde.20230804.14,
author = {Djalogue Lihanimpo and Mossi Komi Edem and Tchamdja Toyi and Djagadou Kodjo Agbeko and Balaka Abago and Djibril Mohaman Awalou},
title = {Hyperthyroidism at Kara Teaching Hospital About 33 Cases Studies},
journal = {International Journal of Diabetes and Endocrinology},
volume = {8},
number = {4},
pages = {60-63},
doi = {10.11648/j.ijde.20230804.14},
url = {https://doi.org/10.11648/j.ijde.20230804.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20230804.14},
abstract = {The objective of this study was to describe the epidemiological, clinical, paraclinical and etiological profiles of hyperthyroidism at Kara Teaching Hospital. This was a retrospective study of the records of patients followed for hyperthyroidism in the internal medicine and endocrinology department of the Kara Teaching Hospital from June 2021 to March 2023. During this study period, 33 (2.24%) of the 1476 patients had hyperthyroidism. Women accounted for 81.82% of cases. The mean age was 44.72 +/- 15.76 with extremes ranging from 10 to 71 years. Goiter was found in 78.79% of cases, followed by asthenia 72.73% and tachycardia 60.61%. The causes of hyperthyroidism were Graves' disease in 36.36% of cases, thyroiditis in 30.30% of cases, toxic multinodular goiter in 27.27% of cases, and toxic nodule in 6.06% of cases. 6% of patients had complications such as cardiothyreosis. The course with synthetic antithyroids was favorable with normalization of thyroid hormones. Finally, 30% of the patients had been operated on. Hyperthyroidism is very common in hospitals in Kara with a female predominance. The clinical signs are varied and the main cause is Graves' disease.
},
year = {2023}
}
TY - JOUR T1 - Hyperthyroidism at Kara Teaching Hospital About 33 Cases Studies AU - Djalogue Lihanimpo AU - Mossi Komi Edem AU - Tchamdja Toyi AU - Djagadou Kodjo Agbeko AU - Balaka Abago AU - Djibril Mohaman Awalou Y1 - 2023/12/06 PY - 2023 N1 - https://doi.org/10.11648/j.ijde.20230804.14 DO - 10.11648/j.ijde.20230804.14 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 60 EP - 63 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20230804.14 AB - The objective of this study was to describe the epidemiological, clinical, paraclinical and etiological profiles of hyperthyroidism at Kara Teaching Hospital. This was a retrospective study of the records of patients followed for hyperthyroidism in the internal medicine and endocrinology department of the Kara Teaching Hospital from June 2021 to March 2023. During this study period, 33 (2.24%) of the 1476 patients had hyperthyroidism. Women accounted for 81.82% of cases. The mean age was 44.72 +/- 15.76 with extremes ranging from 10 to 71 years. Goiter was found in 78.79% of cases, followed by asthenia 72.73% and tachycardia 60.61%. The causes of hyperthyroidism were Graves' disease in 36.36% of cases, thyroiditis in 30.30% of cases, toxic multinodular goiter in 27.27% of cases, and toxic nodule in 6.06% of cases. 6% of patients had complications such as cardiothyreosis. The course with synthetic antithyroids was favorable with normalization of thyroid hormones. Finally, 30% of the patients had been operated on. Hyperthyroidism is very common in hospitals in Kara with a female predominance. The clinical signs are varied and the main cause is Graves' disease. VL - 8 IS - 4 ER -
Department of Internal Medicine, University of Kara, Kara, Togo
